Loading...
XSHE000650
Market cap1.06bUSD
Jan 14, Last price  
5.63CNY
1D
2.18%
1Q
-3.60%
Jan 2017
-20.14%
Name

Renhe Pharmacy Co.

Chart & Performance

D1W1MN
XSHE:000650 chart
P/E
13.74
P/S
1.55
EPS
0.41
Div Yield, %
3.58%
Shrs. gr., 5y
2.29%
Rev. gr., 5y
2.71%
Revenues
5.03b
-2.35%
280,391,321267,138,38924,943,408778,664,871876,460,543982,736,8271,366,781,2962,207,708,5392,087,519,1611,799,375,8362,253,212,4352,523,842,6633,567,078,2603,843,771,3514,403,423,4744,581,171,5794,106,104,1874,935,755,2085,153,215,0695,032,146,123
Net income
567m
-1.25%
00130,301,62139,170,35170,161,003165,493,385219,530,952300,353,372255,461,059194,182,835300,907,595391,303,600372,380,254380,226,696506,464,000537,826,647580,180,490665,024,502574,430,143567,257,498
CFO
577m
-54.53%
17,553,6280235,279,50335,397,39762,141,462200,579,110130,072,804166,926,090183,966,860213,355,358365,274,345434,765,147522,083,291497,855,600569,454,435693,970,679871,131,642777,717,5301,269,978,522577,442,920
Dividend
Jul 08, 20240.2 CNY/sh
Earnings
May 23, 2025

Profile

Renhe Pharmacy Co., Ltd. produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, topical lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.
URL
https://www.renheyaoye.com/photography
IPO date
Dec 10, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
5,032,146
-2.35%
5,153,215
4.41%
Cost of revenue
3,606,568
3,943,991
Unusual Expense (Income)
NOPBT
1,425,578
1,209,224
NOPBT Margin
28.33%
23.47%
Operating Taxes
269,450
241,983
Tax Rate
18.90%
20.01%
NOPAT
1,156,129
967,241
Net income
567,257
-1.25%
574,430
-13.62%
Dividends
(279,419)
(139,994)
Dividend yield
3.05%
1.62%
Proceeds from repurchase of equity
(60,078)
BB yield
0.65%
Debt
Debt current
6,723
Long-term debt
5,793
11,586
Deferred revenue
37,110
38,828
Other long-term liabilities
182
182
Net debt
(4,067,651)
(3,343,573)
Cash flow
Cash from operating activities
577,443
1,269,979
CAPEX
(186,549)
Cash from investing activities
(366,264)
Cash from financing activities
(421,809)
FCF
773,519
1,071,176
Balance
Cash
3,534,493
3,242,350
Long term investments
538,951
119,532
Excess cash
3,821,836
3,104,221
Stockholders' equity
5,452,989
5,638,235
Invested Capital
2,869,956
3,089,185
ROIC
38.80%
30.95%
ROCE
21.30%
19.52%
EV
Common stock shares outstanding
1,383,555
1,399,938
Price
6.63
7.11%
6.19
-33.58%
Market cap
9,172,969
5.85%
8,665,618
-33.58%
EV
5,766,782
6,003,044
EBITDA
1,567,277
1,326,374
EV/EBITDA
3.68
4.53
Interest
3,732
428
Interest/NOPBT
0.26%
0.04%